Translational Development Acquisition Corp Files Proxy Statement for Shareholder Meeting
Coal Mine Disaster in China Raises Safety Concerns for Industry
General Motors Unveils New AllElectric Cadillac Vistiq With 300Mile Range
Consumer Sentiment Plunges to Historic Low in May Amid USIran Tensions and Soaring Oil Prices
Jobless Claims Remain Low Signaling Persistent Labor Market Strength
BJs Wholesale Announces Major Store Changes Amid Consumer Spending Slowdown
SVRA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development
SWKHL Q3 2025 Earnings Strong EPS Beat of 70 Delivers 59 Cents Per Share
Dave Inc DAVE Q1 2026 Earnings EPS Surges 37 Above Estimates Stock Pulls Back
Soleno Therapeutics Inc SLNO Q1 2026 Earnings Profitability Misses Estimates Amid Zero Revenue
Diversified Healthcare Trust 5625 Senior Notes due 2042 DHCNI Q1 2026 Earnings Deeper EPS Miss Signals Persistent Headwinds
PSQH Q1 2026 Earnings EPS Surprises to the Upside Despite Revenue Absence
Enlivex ENLV Edges Higher After Testing Key Support at 069
AmpcoPittsburgh AP Holds Steady Near 1016 as Support and Resistance Levels Firm
Iron Horse Acquisitions II Corp IRHOU Holds Steady at 1017 Amid Quiet Trading
Amphastar Pharmaceuticals AMPH Bounces Off Support Eyes Resistance at 2028
NVNIW Warrants Surge 1282 as PennyStock Speculation Drives Trading Activity
AIRelated Layoffs and Stock Performance Not Always a Positive Signal
ConAgra Brands CAG Q1 2026 Earnings EPS Misses Estimates Despite Stock Gain
Albemarle ALB Rises 212 as Lithium Demand Optimism Returns Key Levels Ahead
TONX Q1 2026 Earnings EPS Beat Drives 62 Stock Gain as Losses Narrow Sharply
SNOW Q1 2026 Earnings Earnings Beat Drives Stock Higher Amidst Uncertainty on Revenue
SNSE Q1 2026 Earnings Significant EPS Miss Reflects NonCash Adjustments Stock Declines Modestly
CMS Energy CMSD Q1 2026 Earnings Modest EPS Beat Amid Steady Utility Operations
Kroger Q1 2026 Earnings EPS Beat Driven by Operational Efficiency
Mobile Infrastructure Corporation BEEP Q1 2026 Earnings NarrowerThanExpected Loss Despite Stock Decline
SVRA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development